Accentia Biopharmaceuticals sees Q3 loss narrow, receives Nasdaq notice

Accentia Biopharmaceuticals Inc. reported a net loss of $11.4 million, or 25 cents a share, for its fiscal third quarter ended June 30, compared to a net loss of $25 million, or 71 cents a share, in last year's quarter. (ABPI)

Comments off

Kaiser becomes full member of Southwest Oncology Group

Kaiser Permanente’s cancer trial program in Northern California has become a full-fledged member the Southwest Oncology Group, one of the largest cancer clinical-trial cooperative groups in the nation.

Comments off

Kaiser becomes full member of Southwest Oncology Group

Kaiser Permanente’s cancer trial program in Northern California has become a full-fledged member the Southwest Oncology Group, one of the largest cancer clinical-trial cooperative groups in the nation.

Comments off

MicroMet shows promise with latest test results

MicroMet Inc. ’s new approach to using the body’s own immune system to fight cancer has shown dramatic early results. (MITI)

Comments off

Vapotherm closes on nearly $21M round of financing

Respiratory care product developer Vapotherm Inc. has secured nearly $21 million in financing.

Comments off

« Previous entries ·

Nipple Piercings - Call Sri Lanka - Fendi Handbags - Lesotho Phone Cards - Uk Calling Cards